{
    "Allocation": "N/A",
    "CompleteTime": 60,
    "DesignModel": "Single Group Assignment",
    "DrugInformation": {
        "ArmGroupList": [
            {
                "ArmGroupDescription": "g.s.p. oral solution 400 mg/ml:   , ",
                "ArmGroupLabel": "OGSP measurement",
                "ArmGroupType": "Other",
                "InterventionDescription": [
                    {
                        "Dosage": "",
                        "DrugName": "g.s.p. oral solution 400 mg/ml",
                        "Duration": "",
                        "HowToTake": ""
                    }
                ],
                "InterventionList": {
                    "ArmGroupInterventionName": [
                        "Drug: G.S.P. Oral Solution 400 mg/ml"
                    ]
                }
            }
        ]
    },
    "Enrollment": "200",
    "InterventionName": "",
    "Masking": "None (Open Label)",
    "NCTID": "NCT03457311",
    "Objective": "Clinical Study for Development of Oral Galactose Single Point (OGSP) Solution (G.S.P. Oral Solution\u00ae)",
    "OfficialTitle": "Clinical Phase \u2162 Study for Development of Oral Galactose Single Point (OGSP) Solution (G.S.P. Oral Solution\u00ae)",
    "PopulationBox": {
        "Condition": "Galactose Single Point (GSP), Residual Liver Function",
        "Gender": "All",
        "HealthyCondition": "Accepts Healthy Volunteers",
        "MaxAge": "85 Years",
        "MinAge": "20 Years",
        "Participant": "200"
    },
    "PopulationRatio": "",
    "Title": "Clinical Study for Development of Oral Galactose Single Point (OGSP) Solution (G.S.P. Oral Solution\u00ae)",
    "WashoutPeriod": ""
}